Sernova Biotherapeutics (SVA.TO) Q3 2025 Earnings

16SepConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.04
-0.03
-0.02
-0.01

Details

Expected EPS
-0.019832796059999998
Actual EPS
-0.009916398029999999
Surprise EPS
0.01
Surprise Percent
+50%

Description

Sernova Biotherapeutics (SVA.TO) has reported earnings of -0.009916398029999999 per share for Q3 2025.

0 Comments

Share your thoughts